Many covid vaccination registration and information websites at the federal, state and local levels violate disability rights laws, hindering the ability of blind people to sign up for a potentially lifesaving vaccine, a KHN investigation has found.
More
For a long time, researchers have believed Black people would not participate in clinical trials because of the infamous Tuskegee syphilis study. They were wrong. We risk repeating the same mistake with the coronavirus vaccine.
More
There is no “official” definition of structural racism — or of the closely related concepts of systemic and institutional racism — although multiple definitions have been offered.3-7 All definitions make clear that racism is not simply the result of private prejudices held by individuals,8 but is also produced and reproduced by laws, rules, and practices, sanctioned and even implemented by various levels of government, and embedded in the economic system as well as in cultural and societal norms.
More
Lown touched my life through the Right Care Alliance—a sister organization of the Lown Institute. For a slow-adopting, skeptical medical conservative, the annual Lown meeting was nirvana.
Lown meetings were the opposite of cardiology meetings. Cardiology conferences celebrate the science, congratulate the scientists, and promote the latest technology. Lown meetings tackled what is wrong with medicine: overdiagnosis, overtreatment, fractured specialty-centric care, biased evidence, and the crisis in end-of-life care.
An invite to speak at Lown transformed my life. I couldn't believe this many people thought exactly as I do. I met clinicians, editors-in-chief, and researchers who study the state of medical evidence. My modest foray into academic work traces back to the connections I made.
I now realize this was by design. Lown knew that bringing like-minded people together was vital. If somebody takes the initiative, others will see it and follow. A movement grows, then change happens.
More
I understand the vital role vaccines play in ending the Covid-19 pandemic. But what good are vaccines without vaccinations?
More
This cohort study evaluates the differences in survival, duration of therapy, and treatment patterns between clinical trial patients and older adults with Medicare receiving cancer drugs for metastatic solid cancers in usual practice.
More
This randomized clinical trial examines whether a layperson-delivered, empathy-focused program of telephone calls could rapidly improve loneliness, depression, and anxiety in at-risk adults.
More
The rise of telemedicine, the need to move care closer to communities and the likelihood of future viruses are changing the infrastructure of health care.
More
People were dying of a disease that could be treated — but in poor countries, they did not have access to medicines that could help. That was the story of HIV — and now of COVID-19.
More
14 states don’t publicly keep track of COVID-19 data for American Indians/Alaska Natives. “We know who we are, and these are our homelands, so to be rendered invisible is another incidence of historical trauma.”
More
A recent analysis in JAMA finds that overuse in Medicare barely budged from 2014-2018. How can we move further toward value-based care?
More
The Surgeon General nominee will only treat corporate America's woes
More
A new study describes the human toll of private equity firms buying up nursing homes.
More
A year of missed preventive medical care is endangering minority communities.
More
Most drug approvals are based on surrogate markers, such as tumor shrinkage in a fraction of patients (response rate) or delayed tumor growth (progression-free survival). These surrogates use arbitrary percentage cutoffs and are not optimized to ensure that a drug can improve the length or quality of life.
More
The maternal health crisis is an issue where policymakers on both sides of the aisle have and should continue to come together to work toward solutions.
More
Ever since Covid-19 vaccines have been in development, policy experts and activists have been concerned about equity in vaccine distribution. Now, it is clear that in our haste to get "shots in arms," we are leaving behind many people who are most at risk of Covid-19 infection and death.
More
It only makes sense for vaccine allocation to acknowledge these health inequities.
More
Of the 230 trials researchers examined, more than 40% did not record participants’ race and about 65% did not report their ethnicity.
More